Sign up for a free trial and join thousands of other leading professionals. Click here to start!

Cancer News

Home | Index > Health > Hot Topics > Cancer

TAKE THIS POLL
Is Belgian Prime Minister Herman Van Rompuy the right person to lead the EU as its president? (Nov. 20, 2009) Yes. No. Don't know.

Sort by: relevance (24 hours) relevance date

Immune responses in patients with metastatic renal cell carcinoma treated with dendritic cells pulsed with tumor lysate 19 Nov 2009 09:30 GMT
... Department of International Health, Immunology and Microbiology, The ... Copenhagen, Denmark. Patients with metastatic renal cell carcinoma (mRCC) have a limited life expectancy but ... vaccinated with autologous DC pulsed with allogeneic tumour lysate. Low-dose IL-2 administered subcutaneously was given ...
Allogeneic Blood Stem Cell Transplants Using Less Toxic Treatment Regimens (Minitransplants) are a Promising New Cancer Treatment Approach 18 Nov 2009 21:33 GMT
... Treatment Regimens (Minitransplants) are a Promising New Cancer Treatment Approach Allogeneic Blood Stem Cell Transplants ... and/or chemotherapy is widely used to treat leukemias and other cancers of the blood and ... multiple myeloma. Other cancers including renal cell carcinoma and malignant melanoma may also benefit from ...
Opiate Painkillers May Encourage Spread Of Cancer 23 Nov 2009 19:41 GMT
... chronic pain for two hundred years, encourage cancer cells to grow and spread. If confirmed ... Lab studies show that morphine directly boosts tumor cell proliferation and inhibits immune response. Singleton, ... opiates. In one study, they used bronchioloalveolar carcinoma cells and showed that MNTX blocked cancer-promoting ...
Alnylam Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer 18 Nov 2009 12:32 GMT
... RNAi Therapeutic for the Treatment of Liver Cancer CAMBRIDGE, Mass. - (BUSINESS WIRE) - Alnylam ... the treatment of liver cancers, including hepatocellular carcinoma (HCC) and other solid tumors with liver ... liver involvement. The new data demonstrated robust anti-tumor activity in orthotopic liver tumor models comprised ...
Gastric Cancer: New findings from Memorial Sloan Kettering Cancer Center, Department of Surgery in the area of gastric cancer published 19 Nov 2009 05:35 GMT
... indications for type I .' "Most gastric carcinoid tumors (GC) (type I) occur in association ... with (n=19). SR was performed with larger tumor size, increased depth of invasion, and solitary ... R.A. Gladdy and colleagues, Memorial Sloan Kettering Cancer Center, Department of Surgery. The researchers concluded: ...

Hundreds light the night for Leukemia & Lymphoma Society 15 Nov 2009 03:53 GMT
... Hundreds light the night for Leukemia & Lymphoma Society Story Created: Nov 14, ... those whose lives have been touched by Cancer. Hundreds of balloons twinkled in the night ...
AVEO's Triple VEGF Receptor Inhibitor Tivozanib in Combination with mTOR Inhibitor Demonstrates Anti-tumor Activity and Tolerability in Advanced Kidney Cancer; Preliminary Results Presented at AACR-NCI-EORTC Meeting Preclinical Co 17 Nov 2009 17:50 GMT
... AVEO's Triple VEGF Receptor Inhibitor Tivozanib in Combination with mTOR Inhibitor Demonstrates Anti-tumor Activity and Tolerability in Advanced Kidney Cancer; Preliminary Results Presented at AACR-NCI-EORTC Meeting Preclinical Combination Data Also Presented, Demonstrate mTOR-Tivozanib Combination ...
AVEO's Triple VEGF Receptor Inhibitor Tivozanib in Combination with mTOR Inhibitor Demonstrates Anti-tumor Activity and Tolerability in Advanced Kidney Cancer; Preliminary Results Presented at AA 17 Nov 2009 17:50 GMT
... Also Presented, Demonstrate mTOR-Tivozanib Combination in Breast Tumor Model Prevents Emergence of Resistance CAMBRIDGE, Mass.--(BUSINESS ... company focused on discovering, developing and commercializing cancer therapeutics, today announced preliminary results from a ... in a genetically engineered HER2 driven breast adenocarcinoma model were also presented at the meeting. ...
AVEO's Triple VEGF Receptor Inhibitor Tivozanib in Combination with mTOR Inhibitor Demonstrates Anti-tumor Activity and Tolerability in Advanced Kidney Cancer; Preliminary Results Presented at AACR-NCI-EORTC Meeting 17 Nov 2009 17:51 GMT
... Tivozanib in Combination with mTOR Inhibitor Demonstrates Anti-tumor Activity and Tolerability in Advanced Kidney Cancer; Preliminary Results Presented at AACR-NCI-EORTC Meeting Preclinical ... in a genetically engineered HER2 driven breast adenocarcinoma model were also presented at the meeting. ...
AVEO's Triple VEGF Receptor Inhibitor Tivozanib in Combination with mTOR Inhibitor Demonstrates Anti-tumor Activity and 17 Nov 2009 17:52 GMT
... Tivozanib in Combination with mTOR Inhibitor Demonstrates Anti-tumor Activity and Tolerability in Advanced Kidney Cancer; Preliminary Results Presented at AACR-NCI-EORTC Meeting CAMBRIDGE, ... in a genetically engineered HER2 driven breast adenocarcinoma model were also presented at the meeting. ...

Not satisfied with this news section? Make your own with the Newsletter Manager or try our other media monitoring services.

Students raise money for cancer research one penny at a time 18 Nov 2009 08:52 GMT
... school students around the country for the Leukemia & Lymphoma Society's School & Youth Programs, ... to help find a cure for blood-related cancers such as leukemia and lymphoma. By Nov. ...
Students raise money for cancer research, one penny at a time 22 Nov 2009 10:37 GMT
... school students around the country for the Leukemia & Lymphoma Society's School & Youth Programs, ... to help find a cure for blood-related cancers, such as leukemia and lymphoma. By Nov. ...
Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study 20 Nov 2009 07:58 GMT
... Hematology and Oncology, and Department of Medicine, Ohio State University Medical Center and Comprehensive Cancer Center, Columbus, OH. Tumor growth requires the development of independent vascular networks that are often primitive in morphology and ...
Combo Treatment Beneficial in Biliary-Tract Cancer Study 23 Nov 2009 14:50 GMT
... promise in treating patients with advanced biliary-tract cancers, researchers say. The study from the Massachusetts ... Center in Boston found that survival and tumor response in patients treated with bevacizumab (Avastin), an ...
Cancer Research UK in hunt for young heroes 16 Nov 2009 10:55 GMT
... Cancer Research UK in hunt for young heroes ... in Leicestershire via the children's cancer and leukaemia group at Leicester Royal Infirmary. The awards ...
Moffitt Cancer Center Awarded Nearly $19 Million in Recovery Act Grants 19 Nov 2009 18:31 GMT
... related disciplines to study the development of cancer. "Moffitt is making the most of every opportunity ... cancers such as adult glioma, colorectal, multiple myeloma, myelodysplastic syndromes, ovarian and prostate "Expanding our ...
Cancer Science Institute plans to expand 17 Nov 2009 02:35 GMT
... SINGAPORE: The Cancer Science Institute (CSI) of Singapore has just ... researchers on diseases like stomach cancer and leukaemia. The S$256m centre is one of four ...
Cancer Science Institute plans to add 12 more principal investigators 16 Nov 2009 17:13 GMT
... SINGAPORE: The Cancer Science Institute (CSI) of Singapore has just ... researchers on diseases like stomach cancer and leukaemia. The S$256m centre is one of four ...
How Gum Disease Can Destroy Your Health : The Cancer Connection 20 Nov 2009 09:14 GMT
... Disease Can Destroy Your Health : The Cancer Connection By now everyone knows that many things ... pancreatic cancer. Blood cell cancers such as leukemia rose by 30% among men with gum ...
University researchers develop new test for gastrointestinal cancer 20 Nov 2009 09:05 GMT
... University researchers develop new test for gastrointestinal cancer KANAZAWA -- A blood test to screen ... screening methods using blood samples look at tumor markers, a substance that appears with the presence ...

THESE STORIES ARE NOT PUBLISHED BY IPD GROUP, INC. AND THESE LINKS WILL TAKE YOU TO OTHER WEBSITES. SOME OF THESE WEBSITES REQUIRE THEIR OWN REGISTRATION TO READ THEIR STORIES. PLEASE READ THE DISCLAIMER FOR MORE DETAILS. >>>

Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conf 23 Nov 2009 13:30 GMT
... in patients with advanced non-small cell lung cancer (NSCLC). This data is consistent with the ... needs such as those with squamous cell carcinoma," said Kobi Sethna, President and CEO, Nereus ... evaluated in patients with solid tumors, lymphomas, leukemias and multiple myeloma. The Company's discovery portfolio ...
Nereus Pharmaceuticals Presents Positive Interim Data from the ADVANCE Study, a Randomized Phase 2 Clinical Trial of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conference 23 Nov 2009 14:04 GMT
... of Plinabulin (NPI-2358) in Non-Small Cell Lung Cancer at the 2009 EORTC-NCI-AACR Conference )--Nereus Pharmaceuticals, ... needs such as those with squamous cell carcinoma,” said Kobi Sethna, President and CEO, Nereus ... evaluated in patients with solid tumors, lymphomas, leukemias and multiple myeloma. The Company's discovery portfolio ...
Synta Presents Preclinical Data on Next Generation Hsp90 Inhibitor, STA-9090 - Broad anti-cancer activity as a single agent and in combination 18 Nov 2009 13:30 GMT
... Next Generation Hsp90 Inhibitor, STA-9090 - Broad anti-cancer activity as a single agent and in combination ... cancer, gastric cancer, pancreatic cancer, colon cancer, melanoma, acute myeloid leukemia, chronic myeloid leukemia, acute lymphoblastic leukemia, B-cell lymphoma, ...
ImmunoGen, Inc. Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Merkel Cell Carcinoma (BIZ) 17 Nov 2009 17:50 GMT
... activity in the treatment of Merkel cell carcinoma and has been generally well tolerated," commented Professor ... as well as other types of CD56-expressing cancers." IMGN901 is designed to kill cancer cells ... treatment for MCC, small-cell lung cancer, multiple myeloma, ovarian cancers and other CD56+ tumors. It ...
ImmunoGen Announces Encouraging Clinical Data with Its IMGN901 Compound in the Treatment of Merkel Cell Carcinoma 18 Nov 2009 14:55 GMT
... Compound in the Treatment of Merkel Cell Carcinoma WALTHAM, MA, November 17, 2009 – ImmunoGen, Inc. ... IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, today reported encouraging clinical data with ... treatment for MCC, small-cell lung cancer, multiple myeloma, ovarian cancers and other CD56+ tumors. It ...